Associated Papers
Variation Analysis in Premenopausal and Postmenopausal Breast Cancer Cases.
Erdogdu IH et al.
Journal of Personalized Medicine, 2024
Spectrum of PIK3CA/AKT mutations across molecular subtypes of triple-negative breast cancer.
Kumar S et al.
Breast Cancer Research and Treatment, 2021
Neoadjuvant chemotherapy in breast cancer: a dose-dense schedule in real life and putative role of PIK3CA mutations.
Cocciolone V et al.
Oncotarget, 2018
Molecular evaluation of PIK3CA gene mutation in breast cancer: determination of frequency, distribution pattern and its association with clinicopathological findings in Indian patients.
Ahmad F et al.
Medical Oncology (northwood, London, England), 2016
Analysis of PIK3CA exon 9 and 20 mutations in breast cancers using PCR-HRM and PCR-ARMS: correlation with clinicopathological criteria.
Harlé A et al.
Oncology Reports, 2013
Detection of tumor PIK3CA status in metastatic breast cancer using peripheral blood.
Higgins MJ et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2012
Prognostic role of PIK3CA mutation in colorectal cancer: cohort study and literature review.
Liao X et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2012
A platform for rapid detection of multiple oncogenic mutations with relevance to targeted therapy in non-small-cell lung cancer.
Su Z et al.
The Journal of Molecular Diagnostics : Jmd, 2011
PIK3CA mutations in human solid tumors: role in sensitivity to various therapeutic approaches.
Ligresti G et al.
Cell Cycle (georgetown, Tex.), 2009
PIK3CA mutation in colorectal cancer: relationship with genetic and epigenetic alterations.
Nosho K et al.
Neoplasia (new York, N.y.), 2008
PIK3CA mutation is an oncogenic aberration at advanced stages of oral squamous cell carcinoma.
Kozaki K et al.
Cancer Science, 2006
Select a paper to view details